Sepsis Diagnostics Market size and growth: Sepsis Diagnostics market was worth USD 934.54 million in 2018 and is estimated to be growing at a CAGR of 8.51%, to reach USD 1405.88 million by 2023.
Sepsis Diagnostics Market Overview:
Sepsis can be defined as the body's response to an infection by fungi, bacteria, viruses or parasites, which can cause a systemic inflammatory reaction and organ dysfunction. Depending on the severity of the infection, sepsis is classified into three types: sepsis, severe sepsis, and septic shock. Severe sepsis is associated with organ dysfunction and acute deterioration of the mental state, while the septic shock is defined as severe sepsis with signs of abnormal cellular metabolism, hypotension and organ dysfunction. As a medical emergency Sepsis is one of the most frequent causes of death in hospitalized patients.
To know more, read @ https://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market
Sepsis Diagnostics Market Drivers and Restraints:
The main factors that drive the growth of the global sepsis diagnostics market are the increasing prevalence of different bacterial strains resistant to antibiotics, the aging of the population. Greater awareness of health care, besides, it is expected that the growing number of surgical procedures and the increase in the number of product approvals for the diagnosis of sepsis support the growth of the market for the diagnosis of global sepsis in the near future. The high incidence of nosocomial infections is the main factor that accelerates the growth of the world market for the diagnosis of sepsis. According to the Centers for Disease Control and Prevention (CDC) (2011), approximately 1.7 million coronary infections are reported every year in the United States for all types of bacteria combined. Besides, according to the ECDC estimates, nearly 4.1 million patients were diagnosed with an ICD in Europe (including 30 countries) in 2013. However, the lack of standard protocols and the lack of qualified personnel in developing countries prevent The market growth diagnosis of sepsis.
Report Segmented as:
By Pathogen:
• Bacterial Sepsis
o Gram-Negative Bacterial Sepsis
o Gram-Positive Bacterial Sepsis
• Fungal Sepsis
• Other Pathogen Infections
By Product:
• Instruments
• Blood Culture Media
• Assay Kits & Reagents
• Software
By Technology:
• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Other Technologies
By Method:
• Conventional Diagnostics
• Automated Diagnostics
By Usability:
• Laboratory Testing
• Point-of-Care Testing
View a sample and decide @ https://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market/request-sample
Geographical segmentation:
Based on geography, the global sepsis diagnostics market is segmented into five key regions, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominated the global sepsis diagnostics market in 2015 in terms of value, owing to factors such as increasing demand for better healthcare facilities. Growing adoption of new and advanced diagnostic techniques, high per capita healthcare expenditure, and rising incidences of chronic diseases such as cancer, diabetes, etc. Leading to increasing hospital admissions and rising rates of hospital-acquired infection in the U.S. Asia Pacific region is expected to register highest CAGR during the forecast period of 2016-2024, owing to factors such as increasing geriatric population in the region, combined with developing healthcare infrastructure, and rising prevalence of cancer and diabetes in countries such of India, China, and Australia. However, lack of awareness and shortage of skilled workforce in the Asia Pacific regions are some factors restraining the growth of the sepsis diagnostics market in this region.
Key Market Players:
Some of the key players in the global sepsis diagnostics market include BioMérieux SA, Thermo Fisher Scientific, Inc., T2 Biosystems, Inc., Nanosphere, Inc., Cepheid, Roche Diagnostics Limited, Abbott Laboratories, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, and Bruker Corporation among others.
The Scope of the report:
The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed, and the prospects with colossal growth potential identified and debated.
Check for discount: https://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market/discount
About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: [email protected]
Tel: +1-888-702-9626
Website: https://www.marketdataforecast.com/